Yahaya James J, Ngaiza Advera I, Morgan Emmanuel D, Abraham Zephania S, Othieno Emmanuel
Department of Pathology, School of Health Sciences, Soroti University, Soroti, Uganda.
Department of Pathology, Muhimbili University of Health and Allied Sciences, Dar-Es-Salaam, Tanzania; Department of Pathology, Muhimbili National Hospital, Dar-Es-Salaam, Tanzania.
Int J Surg Case Rep. 2023 Apr;105:108121. doi: 10.1016/j.ijscr.2023.108121. Epub 2023 Apr 4.
Male breast cancers despite being similar to female breast cancers in various aspects; however, they have important distinctive characteristics such as molecular biology, increased tendency for axillary lymph node metastasis and late age at presentation.
We present the case of a 73-year old indigenous African male who had a 3-year history of right breast swelling which was associated with episodes of pain and tenderness. The assigned clinical stage for the patient was T2aNoMo. The mass was histologically confirmed to be invasive ductal carcinoma, not specified type (NST) without axillary lymph node involvement or distant metastasis. Immunohistochemistry also showed positive results for ER and PR hormonal receptors but negative for HER2.
Considering the rarity nature of male breast cancers, this contributes to lack of evidence of the specific treatment approaches despite the noticeable difference in clinical presentation and even biological characteristics of male breast cancers, which are more likely to contribute to poor prognosis.
The prevalence of male breast cancers has been reported to be less than 1 % of all male cancers. This contributes to the lack of analytical large studies that address the comprehensive data regarding the clinical outcomes of breast cancer among men and their predictors. Therefore, having prospective multicenter studies in future would help in providing high level of evidence on prognosis.
男性乳腺癌尽管在诸多方面与女性乳腺癌相似;然而,它们具有重要的独特特征,如分子生物学、腋窝淋巴结转移倾向增加以及就诊时年龄较大。
我们报告一例73岁的非洲本土男性病例,其右乳肿胀3年,伴有疼痛和压痛发作。患者的临床分期为T2aNoMo。肿块经组织学确诊为浸润性导管癌,非特殊类型(NST),无腋窝淋巴结受累或远处转移。免疫组化显示雌激素受体(ER)和孕激素受体(PR)呈阳性,但人表皮生长因子受体2(HER2)呈阴性。
鉴于男性乳腺癌的罕见性,尽管男性乳腺癌在临床表现甚至生物学特征上存在明显差异,这更可能导致预后不良,但仍缺乏特定治疗方法的证据。
据报道,男性乳腺癌的患病率不到所有男性癌症的1%。这导致缺乏分析性大型研究来处理关于男性乳腺癌临床结局及其预测因素的全面数据。因此,未来进行前瞻性多中心研究将有助于提供关于预后的高水平证据。